The characteristics and outcomes of 681 severe cases with COVID-19 in China

Kakodkar, 2020, A comprehensive literature review on the clinical presentation, and management of the Pandemic Coronavirus Disease 2019 (COVID-19), Cureus, 12 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5 Grasselli, 2020, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy, JAMA, 323, 1574, 10.1001/jama.2020.5394 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Wu, 2020, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China, JAMA, 10.1001/jama.2020.2648 Li, 2020, Coronavirus disease 2019 (COVID-19): current status and future perspective, Int J Antimicrob Agents, 2019, 105951, 10.1016/j.ijantimicag.2020.105951 Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Cataudella, 2017, Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia, J Am Geriatr Soc, 65, 1796, 10.1111/jgs.14894 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 Du, 2020, Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study, Eur Respir J, 55, 2000524, 10.1183/13993003.00524-2020 Cao, 2020, A trial of Lopinavir–ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 Khamitov, 2008, Antiviral activity of arbidol and its derivatives against the pathogen of severe acute respiratory syndrome in the cell cultures, Vopr Virusol, 53, 9 Ströher, 2004, Severe acute respiratory syndrome–related coronavirus is inhibited by interferon-α, J Infect Dis, 189, 1164, 10.1086/382597 Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 17, 259, 10.1038/s41569-020-0360-5 Yang, 2020, Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int J Infect Dis, 94, 91, 10.1016/j.ijid.2020.03.017 Vaduganathan, 2020, Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19, N Engl J Med, 382, 1653, 10.1056/NEJMsr2005760 Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis, ciaa248